Previous Close | 2.7000 |
Open | 2.8400 |
Bid | 2.5300 x 800 |
Ask | 2.8700 x 900 |
Day's Range | 2.7000 - 2.8896 |
52 Week Range | 1.9100 - 8.7600 |
Volume | |
Avg. Volume | 73,075 |
Market Cap | 14.005M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.4180 |
Earnings Date | Nov 08, 2022 - Nov 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.25 |
Subscribe to Yahoo Finance Plus to view Fair Value for YTEN
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -1.45% and 37.20%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
-Winter program targeting more than 1,000 acres through grower contracts -On track to achieve key 2022 goal of identifying herbicide tolerant Camelina lines for seed scale up and commercial development -Management will host a conference call today at 4:30 p.m. (ET) to review financial results and provide a corporate update WOBURN, Mass., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financ
WOBURN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2022 financial results and provide a corporate update on Wednesday, August 10, 2022. Management will host a conference call on Wednesday, August 10, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following manag